Skip to main content
HR 5416 117th Congress House Health

Give Kids a Chance Act

Introduced: September 29, 2021 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2021
Referred to the Subcommittee on Health.
Sep 29, 2021
Referred to the House Committee on Energy and Commerce.
Sep 29, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Give Kids a Chance Act

This bill authorizes the Food and Drug Administration (FDA) to take various actions regarding pediatric cancer treatments, such as requiring pediatric cancer trials involving a combination of drugs when an applicant seeks market approval for a new drug (or biological product).

For an application for market approval for a new adult cancer treatment drug, if the FDA determines that the drug in question is substantially relevant to the growth or progression of a pediatric cancer, the FDA may require a pediatric cancer investigation into that drug's active ingredient in combination with another active ingredient that has received market approval or an exemption for investigational use. Currently, the FDA may only require a pediatric cancer trial for the drug in the application.

Furthermore, when the FDA receives an application for an investigational use exemption for an adult cancer treatment drug, the FDA may require the applicant to conduct up to two preclinical studies to determine the relevance of the drug to pediatric cancer.

What's happening now September 30, 2021

Referred to the Subcommittee on Health.

 Related & companion bills 2
  • HR 6972 Related bill Give Kids a Chance Act of 2022
  • S 4215 Related bill Give Kids a Chance Act of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 5
All 5 Democratic 2 Republican 1
O'Halleran, Tom
· Mar 7, 2022
 D
Ross, Deborah K.
North Carolina · Feb 3, 2022
Higgins, Brian
· Feb 1, 2022
 D
Cohen, Steve
Tennessee · Jan 19, 2022
 R
McCaul, Michael T.
Texas · Sep 29, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5416: Give Kids a Chance Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5416/
MLA
"H.R. 5416: Give Kids a Chance Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5416/.
Bluebook (legal)
H.R. 5416, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5416/.
Markdown link
[H.R. 5416: Give Kids a Chance Act](https://openamerica.io/bill/117-HR-5416/)
Report a problem